期刊文献+

碳纳米管携载顺铂逆转卵巢癌耐药性的实验研究 被引量:3

Enhancement of Anticancer Effects of Cisplatin Carried by Single-Walled Carbon Nanotubes to Human Ovarian Carcinoma Cisplatin-Resistant Cells
下载PDF
导出
摘要 目的:研究以荧光标记的大孔径碳纳米管为载体,内载顺铂,作用于顺铂耐药的卵巢癌细胞株,逆转细胞耐药性,增加顺铂对细胞的杀伤作用。方法:携带荧光标记物的碳纳米管内载顺铂后与卵巢癌耐药细胞株共培养,通过荧光显微镜检测碳纳米管载体进入细胞内的量,流式细胞仪检测载体增加顺铂对癌细胞的杀伤性能,高效液相色谱法检测载体增加细胞内顺铂含量。结果:①荧光显微镜检测结果:随着单壁碳纳米管(SWNTs)浓度(6μg/ml、12.5μg/ml、25μg/ml、50μg/ml、100μg/ml、200μg/ml)的增加,顺铂-SWNTs粒子进入卵巢癌耐药COC1/DDP细胞株的量也增加;②流式细胞仪检测:浓度高于1×10-3mg/ml时,顺铂对细胞产生了明显的凋亡效应;③高效液相色谱法检测:作用2小时后,100μg/ml和50μg/ml浓度加载体组细胞内顺铂含量[(10.1478±1.2362)×10-6ng、(9.3208±1.4302)×10-6ng]比不加载体组细胞内顺铂含量[(4.2835±0.7728)×10-6ng、(4.6852±1.0038)×10-6ng]明显增多(P<0.01)。结论:功能化的碳纳米管有望成为新的化疗药物载体,携带抗癌药物,通过增加细胞内药物浓度,逆转肿瘤耐药性,降低化疗药物的毒副反应。 Objective:To study the anticancer potential of single-walled carbon nanotubes(SWNTs) loaded with cisplatin and rhodamine in human ovarian carcinoma cisplatin-resistant cells.Methods:Cisplatin carried by SWNTs was co-cultured with human ovarian carcinoma cisplatin-resistant cells. The dosage of SWNTs vector entered into cells was observed by fluorescence microscopy The cytotoxic effect of cisplatin-loaded SWNTs on the proliferation of human ovarian carcinoma cisplatin-resistant cells was observed by flow cytometry. The determination of cisplatin in cells was observed by high performance liquid chromatography(HPLC) .Results:①The results under fluorescence microscope showed that the higher the concentration of SWNTs(6 μg/ml、12.5 μg/ml、25 μg/ml、50 μg/ml、100 μg/ml、200 μg/ml) ,the higher of cisplatin-SWNTs entering ovarian cancer Cisplatin-Resistant Cells COC1/DDP. ②Flow Cytometry showed that when the concentration was over 1×10-3 mg/ml,there was obvious apoptosis. ③ HPLC showed that there was obvious increased of cisplatin in vector plus concentration of 100 μg/ml and 50 μg/ml[(10.1478±1.2362) ×10-6 ng、(9.3208±1.4302) ×10-6 ng] than without vector group [(4.2835±0.7728) ×10-6 ng、(4.6852±1.0038) ×10-6 ng](P0.01) 2 hours after action. Conclusions:SWNTs is to be a good vector for chemotherapy,which can carrier anticancer drugs,increase the concentration of medicine in cell,inverse tumor drug resistance,decrease the side effects of chemotherapy.
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2011年第10期758-761,共4页 Journal of Practical Obstetrics and Gynecology
关键词 碳纳米管 药物载体 顺铂 耐药卵巢癌细胞 Single-walled carbon nanotubes Drug agent Cisplatin Human ovarian carcinoma cisplatin-resistant cells
  • 相关文献

参考文献10

  • 1Bianco A. Carbon nanotubes for the delivery of therapeutic molecules [J]. Expt Opin Drug Deliv,2004,34( 1 ) : 57 -65.
  • 2Bianco A, Kostarelos K, Partidos CD, et al. Biomedical applications of functionalised carbon nanotubes [ J ]. Chem Commun, 2005,60 (5) : 571 -577.
  • 3Cleare M J, Hydes PC, Malerbi BW, et al. Anti-tumor platinum com- plexes: relationships between chemical properties and activity [ J ]. Bioehimie, 1998, 60 (23) : 835 - 850.
  • 4彭芸花,金玉,王兴秀,孙少伯.顺铂载入碳纳米管内增加其抗肿瘤性的研究[J].中国临床药理学杂志,2010,26(12):920-922. 被引量:4
  • 5Kam NW, Jessop TC, Wender PA, et al. Nanotube molecular trans- porters internalization of carbon nanotube-protein conjugates into mammalian cells [ J ]. J Am Cbem Soc, 2004, 126 (22) : 6850 -6851.
  • 6Kam NW, Liu Z, Dai H. Carbon nanotubes as intracellular transport- ers for protein and DNA: an investigation of the uptake mechanism and pathway [ J ]. Angew Chem Int Ed Engl, 2005,45 ( 4 ) : 577 -581.
  • 7Lopez CF, Nielsen SO, Moore PB, et al. Understanding nature's de- sign for nanosyringe[ J]. Proc Natl Acad Sci USA, 2004,101 ( 13 ) : 4431 - 4434.
  • 8Poon RT, Fan ST, Wong J. Risk factors, prevention and management of postoperative recurrence after resection of hepatocellular carcinoma [ J]. Ann Surg,2000,232( 1 ) :10 - 12.
  • 9Odom TW, Huang JL, Kim P, et al. Structure and electronic properties of carbon nanotubes [ J ]. Phys Chem B, 2000, 104 ( 13 ) : 2794 - 2809.
  • 10加福民,许海燕.碳纳米管进入细胞的机制及其在细胞中的定位研究进展[J].生物医学工程学杂志,2010,27(1):198-201. 被引量:4

二级参考文献32

  • 1LIJIMA S. Helical microtubules of graphitic carbon[J]. Nature, 1991,354(1) : 56-58.
  • 2PANTAROTTO D, SINGH S, MCCARTHY D, et al. Functionalized carbon nanotubes for plasmid DNA gene delivery[J]. Angewandte Chemic International Edition, 2004, 43 (39) : 5242-5246.
  • 3KAM N W S, DAI H J. Regular arrays of 2 nm metal nanoparticles for deterministic synthesis of nanomaterials[J]. Journal of the American Chemical Society, 2005, 127(34) : 6021- 6026.
  • 4RODNEY P F, NOZOMI N R, DAI H J, et al. Soluble single-walled carbon nanotubes as longboat delivery systems for platinum (IV) anticancer drug design[J]. Journal of the American Chemical Society, 2007, 129(27): 8438-8439.
  • 5CHEN X, KIS A, ZETTL A, et al. A cell nanoinjector based on carbon nanotubes[J]. Proc Natl Acad Sci, 2007, 104 (20) :8218-8222.
  • 6KAM N W S, JESSOP T C, WENDER P A, et aL Nanotube molecular transporters: Internalization of carbon nanotube - protein conjugates into mammalian cells[J]. Journal of the American Chemical Society, 2004, 126(22) : 6850-6851.
  • 7JIN H, HELLER D A, STRANO M S. Single-particle tracking of endocytosis and exocytosis of single-walled carbon nanotubesin NIH-3T3 cells[J]. Nano Lett, 2008, 8 (6):1577-1585.
  • 8BOTTINI M, CERIGNOLI F, DAWSON M I, et al. Full- length single-walled carbon nanotubes decorated with streptavidin-conjugated quantum dots as multivalent intracellular fluorescent nanoprobes [J]. Biomacromolecules, 2006, 7 (8) : 2259-2263.
  • 9BOTTINI M, CERIGNOLI F, DAWSON M I, et al. Direct imaging of single-walled carbon nanotubes in cells[J]. Nature Nano, 2007, 2(11): 713-717.
  • 10KAM N W S, DAI H J. Carbon nanotubes as intracellular protein transporters: generality and biological functionality[J].Journal of the American Chemical Society, 2005, 127 (16) : 6021-6026.

共引文献6

同被引文献33

  • 1张晓菁,温泽清,张华玲,姚晓奕,李长忠.小干扰RNA抑制多药耐药基因表达并逆转耐药[J].中国实用妇科与产科杂志,2006,22(1):29-31. 被引量:3
  • 2仲建新,曹新平,王迪,张弘,丁润生,姜胜华,江枫,姚微,黄华,史锦云.醋酸甲羟孕酮增强顺铂对人卵巢癌耐药细胞抗癌作用的研究[J].现代妇产科进展,2007,16(8):594-598. 被引量:9
  • 3连利娟;林巧稚.妇科肿瘤学[M]北京:人民卫生出版社,2000410-424.
  • 4Iyer R R,Pluciennik A,Burdett V. DNA mismatch repair:functions and mechanisms[J].Chemical Reviews,2006,(02):302-323.
  • 5Yamane K,Schupp J E,Kinsella T J. BRCA1 activates a G2-M cell cycle checkpoint following 6-thioguanine induced DNA mismatch damage[J].Cancer Research,2007,(13):6286-6292.
  • 6Woodhouse B C,Dianova I I,Parsons J L. Poly(ADP-ribose)polymerase-1 modulates DNA repair capacity and prevents formation of DNA double strand breaks[J].Dna Repair,2008,(06):932-940.
  • 7Anderson G L,Mcintosh M,Wu L. Assessing lead time of selected ovarian cancerbiomarkers:a nested case-control study[J].Journal of the National Cancer Institute,2010,(01):26-38.doi:10.1093/jnci/djp438.
  • 8Mcintosh M W,Drescher C,Karlan B. Combining CA125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma[J].Gynecologic Oncology,2004,(01):9-15.
  • 9Rump A,Morikawa Y,Tanaka M. Binding of ovarian cancer antigen CA125/MUC16 tomesothelin mediates cell adhesion[J].Journal of Biological Chemistry,2004,(10):9190-9198.doi:10.1074/jbc.M312372200.
  • 10Cheng W F,Huang C Y,Chang M C. High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma[J].British Journal of Cancer,2009,(07):1144-1153.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部